Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
MedTech
J&J CEO says M&A strategy to 'continue' after medtech megadeals
After inking more than $30 billion in M&A within two years, CEO Joaquin Duato said that strategy will continue as it hunts for long-term growth.
Conor Hale
Apr 16, 2024 1:42pm
J&J funds Rallybio in risk-busting rare pregnancy disease pact
Apr 10, 2024 4:00pm
J&J's Abiomed pump reduces deaths after widowmaker heart attacks
Apr 8, 2024 12:12pm
J&J adds Shockwave to its cardio collection with $13.1B deal
Apr 5, 2024 11:00am
J&J targets rare maternal-fetal disease: 'We're going for this'
Apr 2, 2024 11:23am
J&J, Trial Library expand partnership on trial recruitment tools
Mar 22, 2024 10:17am